Are we witnessing the demise of big pharma? Channel 4 News #market #research #reports

Posted On Aug 15 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Research – Development News Channel #beta #pharma

Posted On Aug 12 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …


ITTS – An effective Lead Generation model delivering ROI #lead #generation, #business #opportunities, #roi, #identify

Posted On Aug 3 2017 by

# Lead Generation An effective Lead Generation model delivering ROI The aim of our lead generation service is to identify requirements for our clients products and then to develop and qualify these business opportunities. We have highly effective lead generation models which deliver a tangible return on investment with results on a par with those you would expect from your own sales team. Whether it be rapid injection of new pipeline over a short period of time, prolonged management of prospecting in a given market or setting up of diarised sales appointments, ITTS has a long and proven track record. …


Research – Development News Channel #pharmaceutical #reps

Posted On Jul 13 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …


Are we witnessing the demise of big pharma? Channel 4 News #top #ten #pharmaceutical #companies

Posted On Jul 9 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Research – Development News Channel #pharmacy #industry #news

Posted On Jul 6 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …


Are we witnessing the demise of big pharma? Channel 4 News #pharma #recruiters

Posted On May 14 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Are we witnessing the demise of big pharma? Channel 4 News #gland #pharma

Posted On Apr 27 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Are we witnessing the demise of big pharma? Channel 4 News #pharmaceutical #healthcare #companies

Posted On Apr 20 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Research – Development News Channel #msd #pharma

Posted On Apr 14 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …